These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8062156)

  • 1. beta 2-Microglobulin in Paget's bone disease.
    Rico H; Ripoll E; Arribas I; Revilla M; Relea P; Villa LF; de Buergo MA
    Calcif Tissue Int; 1994 May; 54(5):389-91. PubMed ID: 8062156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-2-microglobulin in diseases with high bone remodeling.
    Ripoll E; Arribas I; Relea P; Varela L; Villa LF; Revilla M; Rico H
    Calcif Tissue Int; 1995 Oct; 57(4):272-6. PubMed ID: 8673864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?].
    Wilczek H
    Cas Lek Cesk; 1997 Dec; 136(23):730-2. PubMed ID: 9476376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic-dependent increase of serum beta 2-microglobulin levels in patients with Paget's disease of bone.
    Fiore CE; Foti R; Tamburino C
    Horm Metab Res; 1992 Mar; 24(3):143-4. PubMed ID: 1577406
    [No Abstract]   [Full Text] [Related]  

  • 6. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone alkaline phosphatase in Paget's disease.
    Deftos LJ; Wolfert RL; Hill CS
    Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
    Torres R; de la Piedra C; Rapado A
    Calcif Tissue Int; 1991 Jul; 49(1):14-6. PubMed ID: 1893290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum magnesium concentration in Paget's disease of bone (osteitis deformans).
    Taylor WH
    Ann Clin Biochem; 1985 Nov; 22 ( Pt 6)():591-5. PubMed ID: 4073791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New evidence that serum beta(2)-microglobulin behaves as a biological marker of bone remodelling in women.
    Ripoll E; Revilla M; Hernández ER; Arribas I; Villa LF; Rico H
    Eur J Clin Invest; 1996 Aug; 26(8):681-5. PubMed ID: 8872064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment.
    Coulton LA; Preston CJ; Couch M; Kanis JA
    Arthritis Rheum; 1988 Sep; 31(9):1142-7. PubMed ID: 3048274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum osteocalcin concentrations in Paget's disease of bone.
    Wilkinson MR; Wagstaffe C; Delbridge L; Wiseman J; Posen S
    Arch Intern Med; 1986 Feb; 146(2):268-71. PubMed ID: 3484940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.
    Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ
    Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
    Garnero P; Delmas PD
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
    Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential response of serum alkaline phosphatase and serum osteocalcin in Paget's osteosarcoma.
    Davie MW; Worsfold M; Sharp CA
    Ann Clin Biochem; 1991 Mar; 28 ( Pt 2)():194-5. PubMed ID: 1859160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone.
    Sinigaglia L; Varenna M; Binelli L; Beltrametti P; Zucchi F; Arrigoni M; Frignani S; Abbiati G
    Calcif Tissue Int; 1997 Oct; 61(4):279-84. PubMed ID: 9312197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.